Veness Adam M's Form 4 filing
Dianthus Therapeutics, Inc. (DNTH) · filed Aug 11, 2026
- Accession no.
- 0001778623-26-000007
- Filed
- Aug 11, 2026, 5:08 PM ET
- Trade date
- Aug 7-10, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.21M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Veness Adam MCIK 0001778623 | Officer (SVP, General Counsel and Sec.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | MOption exerciseAcquired | +3,833 | $17.88 | +$68,534.04 | 3,833 | Direct | |
| Aug 7, 2026 | Common Stock | SSaleDisposed | −3,217 | $110.61 | −$355,832.37 | 616 | Direct | |
| Aug 7, 2026 | Common Stock | SSaleDisposed | −616 | $111.18 | −$68,486.88 | 0 | Direct | |
| Aug 10, 2026 | Common Stock | MOption exerciseAcquired | +16,167 | $17.88 | +$289,065.96 | 16,167 | Direct | |
| Aug 10, 2026 | Common Stock | SSaleDisposed | −16,167 | $110.38 | −$1,784,513.46 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | MOption exerciseDisposed | −3,833 | $0.00 | $0 | 76,167 | Direct | |
| Aug 10, 2026 | Common Stock | MOption exerciseDisposed | −16,167 | $0.00 | $0 | 60,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.